Emtricitabine and Tenofovir Disoproxil Fumarate

Product NDC
70518-3077
11-digit product format
705183077
Labeler code
70518
Product ID
70518-3077_c5498de6-9201-23d6-e053-2a95a90add10
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Emtricitabine and Tenofovir Disoproxil Fumarate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA090513
Marketing category
ANDA
Marketing start
2021-04-22
Marketing end
0000-00-00
Substance
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active strength
200 mg/1; mg/1
Pharmacologic classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
70518-3077-07051830770030 TABLET, FILM COATED in 1 BLISTER PACK (70518-3077-0) 2021-04-220000-00-00NoNoCurrent
70518-3077-1705183077014 TABLET, FILM COATED in 1 BLISTER PACK (70518-3077-1) 2021-05-260000-00-00NoNoCurrent
70518-3077-2705183077023 TABLET, FILM COATED in 1 BLISTER PACK (70518-3077-2) 2021-06-180000-00-00NoNoCurrent